(PhysOrg.com) -- The initial entry of HIV-1 into host cells remains a compelling yet elusive target for the development of agents to prevent infection, a critical need in the fight against the global AIDS epidemic.
Biochemistry
Jul 8, 2011
1
0
How about someone who didn't have the disease—would they pay anything? And what if that person smoked?
Economics & Business
Dec 1, 2015
0
5
MIT engineers have designed a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria.
Bio & Medicine
Feb 22, 2011
0
0
Rhesus macaques don't monkey around when it comes to HIV; they have a protein that effectively disables invading HIV particles.
Cell & Microbiology
May 5, 2020
1
78
Experts had greeted with enthusiasm efforts from the self-proclaimed world's largest gay dating app to promote regular HIV testing and status disclosure—but the effort backfired badly with the revelation that Grindr was ...
Internet
Apr 3, 2018
0
19
(PhysOrg.com) -- A new advance by UCLA biochemists has brought scientists one step closer to developing treatments that could delay the onset of Alzheimer's disease and prevent the sexual transmission of HIV.
Biochemistry
Jun 23, 2011
0
0
(PhysOrg.com) -- Cell-penetrating peptides, such as the HIV TAT peptide, are able to enter cells using a number of mechanisms, from direct entry to endocytosis, a process by which cells internalize molecules by engulfing ...
Biotechnology
Oct 4, 2011
1
0
In a recently published study in the journal Nature Microbiology, researchers at Los Alamos National Laboratory show that computer simulations can accurately predict the transmission of HIV across populations, which could ...
Cell & Microbiology
Aug 1, 2018
0
222
A collaborative team led by a Northeastern University professor may have altered the way we look at drug development for HIV by uncovering some unusual properties of a human protein called APOBEC3G (A3G).
Biochemistry
Nov 25, 2013
0
0
Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in ...
Bio & Medicine
Feb 21, 2017
0
32
